Take control of your diabetes

Talk to your healthcare professional

Make the switch from Libre and continue to
manage your diabetes confidently with Dexcom G7.
Get your prescription now. It’s easy.
One option is to see your healthcare professional.
  • Download the G7 Discussion

Get a prescription today

If you’re not able to do that quickly, then various digital health solutions in Canada may be able to help you today.
If you live in Alberta, British Columbia, Ontario, or Quebec you can turn to Mednow, one of our Canadian telehealth partners. Connect virtually with a nurse practitioner, who can discuss your glucose monitoring options and provide a prescription online.
Indications for Use:
The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 CGM System or G7) is a glucose monitoring system indicated for continuously measuring glucose in the interstitial fluid in persons age 2 years and older. The Dexcom G7 CGM System is designed to replace fingerstick blood glucose (BG) testing for treatment decisions. Interpretation of the Dexcom G7 CGM System results should be based on glucose trends and several sequential sensor readings over time. The Dexcom G7 CGM System also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. The Dexcom G7 CGM System is intended for use by patients at home and in healthcare facilities.
Dexcom, Dexcom Follow, Dexcom Clarity, Dexcom Share, Share, and Dexcom ONE are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and Share are trademarks or registered trademarks in the U.S. and may be in other countries.
COPYRIGHT © 2023 DEXCOM CANADA, CO. ALL RIGHTS RESERVED. This product is covered by U.S. patent.
MAT-0324